EA201071201A1 - ИНДОЛЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ НИКОТИНОВОГО РЕЦЕПТОРА АЦЕТИЛХОЛИНА ПОДТИПА α-71 - Google Patents

ИНДОЛЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ НИКОТИНОВОГО РЕЦЕПТОРА АЦЕТИЛХОЛИНА ПОДТИПА α-71

Info

Publication number
EA201071201A1
EA201071201A1 EA201071201A EA201071201A EA201071201A1 EA 201071201 A1 EA201071201 A1 EA 201071201A1 EA 201071201 A EA201071201 A EA 201071201A EA 201071201 A EA201071201 A EA 201071201A EA 201071201 A1 EA201071201 A1 EA 201071201A1
Authority
EA
Eurasian Patent Office
Prior art keywords
indoles
modulators
nicotinic receptor
acetylcholine subtype
receptor acetylcholine
Prior art date
Application number
EA201071201A
Other languages
English (en)
Other versions
EA018113B1 (ru
Inventor
Кевин Диннелл
Эндрю П. Лайтфут
Говард Роберт Маршалл
Original Assignee
Глэксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0807050A external-priority patent/GB0807050D0/en
Priority claimed from GB0810229A external-priority patent/GB0810229D0/en
Application filed by Глэксо Груп Лимитед filed Critical Глэксо Груп Лимитед
Publication of EA201071201A1 publication Critical patent/EA201071201A1/ru
Publication of EA018113B1 publication Critical patent/EA018113B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Данное изобретение относится к модуляции никотинового рецептора α7 ацетилхолина (nAChR) соединением формулы (I) или его солью.
EA201071201A 2008-04-17 2009-04-16 Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-71 EA018113B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0807050A GB0807050D0 (en) 2008-04-17 2008-04-17 Novel compounds
GB0810229A GB0810229D0 (en) 2008-06-04 2008-06-04 Novel compounds
PCT/EP2009/054493 WO2009127678A1 (en) 2008-04-17 2009-04-16 Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71

Publications (2)

Publication Number Publication Date
EA201071201A1 true EA201071201A1 (ru) 2011-04-29
EA018113B1 EA018113B1 (ru) 2013-05-30

Family

ID=40791353

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201071201A EA018113B1 (ru) 2008-04-17 2009-04-16 Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-71
EA201071202A EA017726B1 (ru) 2008-04-17 2009-04-16 Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-7

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201071202A EA017726B1 (ru) 2008-04-17 2009-04-16 Индолы в качестве модуляторов никотинового рецептора ацетилхолина подтипа альфа-7

Country Status (19)

Country Link
US (2) US8377941B2 (ru)
EP (2) EP2279184B1 (ru)
JP (2) JP2011516598A (ru)
KR (2) KR20100133016A (ru)
CN (2) CN102066357B (ru)
AR (1) AR071203A1 (ru)
AU (2) AU2009237649B2 (ru)
BR (2) BRPI0911682A2 (ru)
CA (2) CA2725441C (ru)
CL (1) CL2009000916A1 (ru)
EA (2) EA018113B1 (ru)
ES (2) ES2392795T3 (ru)
IL (2) IL208574A (ru)
MX (2) MX2010011358A (ru)
PE (1) PE20091724A1 (ru)
TW (1) TW201004939A (ru)
UY (1) UY31769A1 (ru)
WO (2) WO2009127679A1 (ru)
ZA (2) ZA201006855B (ru)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
CA2697974C (en) 2007-10-18 2015-06-30 Janssen Pharmaceutica Nv Trisubstituted 1,2,4-triazoles
EP2752406A1 (en) 2008-01-30 2014-07-09 Cephalon, Inc. Substituted pyridazine derivatives which have histamine H3 antagonist activity
KR101564303B1 (ko) 2008-03-19 2015-11-06 얀센 파마슈티카 엔.브이. 니코틴성 아세틸콜린 수용체 조절제로서의 삼치환된 1,2,4-트리아졸
WO2009135944A1 (en) 2008-05-09 2009-11-12 Janssen Pharmaceutica Nv Trisubstituted pyrazoles as acetylcholine receptor modulators
BRPI1014471A2 (pt) 2009-04-16 2016-04-05 Proximagen Ltd moduladores derivados de indol do receptor nicotínico alfa 7 de acetilcolina
TWI558398B (zh) 2009-09-22 2016-11-21 諾華公司 菸鹼乙醯膽鹼受體α７活化劑之用途
GB201012686D0 (en) * 2010-07-28 2010-09-15 Glaxo Group Ltd Novel compounds
JO3078B1 (ar) * 2009-11-27 2017-03-15 Janssen Pharmaceutica Nv مورفولينوثيازولات بصفتها منظمات الوستيرية نوع الفا 7 موجبة
CN103443092B (zh) 2011-02-03 2015-11-25 鲁平有限公司 用作α7胆碱受体调节剂的吡咯衍生物
CU24177B1 (es) 2011-02-23 2016-04-25 Lupin Ltd Derivados de heteroarilo como moduladores de nachr alfa 7
BR112013023813A2 (pt) * 2011-03-18 2016-12-13 Novartis Ag combinações de ativadores do receptor acetilcolina nicotínico alfa 7 e antagonistas de mglur5 para uso em dopamina induzida por discinesia na doença de parkinson
JP2014509641A (ja) 2011-03-31 2014-04-21 ルピン・リミテッド アルツハイマー病やパーキンソン病などの神経変性疾患の治療に用いられるニコチン性アセチルコリン受容体モジュレータとしてのピロール誘導体
TW201245185A (en) 2011-04-01 2012-11-16 Lundbeck & Co As H New positive allosteric modulators of nicotinic acetylcholine receptor
WO2013005153A1 (en) 2011-07-05 2013-01-10 Lupin Limited Biaryl derivatives as nachr modulators
EP2822946A1 (en) 2012-03-06 2015-01-14 Lupin Limited Thiazole derivatives as alpha 7 nachr modulators
US20150099758A1 (en) * 2012-05-08 2015-04-09 Anvyl Llc Alpha 7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof
MX2015004285A (es) * 2012-10-02 2015-08-06 Sumitomo Dainippon Pharma Co Ltd Derivado de imidazol.
EP2945936A1 (en) 2012-11-12 2015-11-25 Lupin Limited Thiazole derivatives as alpha 7 nachr modulators
CN103006642B (zh) * 2013-01-04 2014-10-22 中国药科大学 一类炔亚甲基吲哚-2-酮类衍生物的用途
WO2014111839A1 (en) 2013-01-16 2014-07-24 Lupin Limited Pyrrole derivatives as alpha 7 nachr modulators
US10058310B2 (en) 2013-03-13 2018-08-28 Ethicon Llc Electrosurgical device with drum-driven articulation
CA2892682A1 (en) 2013-03-13 2014-09-18 Lupin Limited Pyrrole derivatives as alpha 7 nachr modulators
TW201446243A (zh) 2013-06-03 2014-12-16 Lupin Ltd 4-(5-(4-氯苯基)-2-(2-環丙基乙醯基)-1,4-二甲基-1氫-吡咯-3-基)苯磺醯胺作為α7尼古丁乙醯膽鹼受體調節劑
AU2014282886A1 (en) 2013-06-17 2015-12-17 Lupin Limited Pyrrole derivatives as alpha 7 nAChR modulators
US20170182058A1 (en) * 2014-03-25 2017-06-29 Emicipi Llc Treatment of rett syndrome
JP6870304B2 (ja) * 2016-12-05 2021-05-12 住友電気工業株式会社 半導体装置の製造方法
US11046683B2 (en) 2016-12-15 2021-06-29 Ono Pharmaceutical Co., Ltd. Activator of TREK (TWIK RElated K+ channels) channels
HU231414B1 (hu) 2018-07-13 2023-08-28 Richter Gedeon Nyrt. Tiadiazin származékok
HU231478B1 (hu) 2018-07-13 2024-02-28 Richter Gedeon Nyrt. Szubsztituált (aza)indol származékok
HU231333B1 (hu) * 2018-07-13 2023-01-28 Richter Gedeon Nyrt Spirokromán származékok
CA3162166A1 (en) * 2019-12-02 2021-06-10 Storm Therapeutics Limited Polyheterocyclic compounds as mettl3 inhibitors
CN111285792B (zh) * 2020-03-23 2023-05-02 三峡大学 2-取代吲哚化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903997D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New compounds
GB0403155D0 (en) * 2004-02-12 2004-03-17 Vernalis Res Ltd Chemical compounds
CA2713519A1 (en) * 2008-02-07 2009-08-13 Abbott Laboratories Amide derivatives as positive allosteric modulators and methods of use thereof

Also Published As

Publication number Publication date
MX2010011358A (es) 2010-11-10
AU2009237650B2 (en) 2012-05-31
CA2721630A1 (en) 2009-10-22
KR20100133016A (ko) 2010-12-20
UY31769A1 (es) 2009-09-30
IL208575A0 (en) 2010-12-30
BRPI0911682A2 (pt) 2015-10-13
AU2009237650A1 (en) 2009-10-22
CN102066357B (zh) 2014-04-09
AU2009237649B2 (en) 2012-07-26
ES2392796T3 (es) 2012-12-13
ZA201006856B (en) 2011-06-29
CA2725441C (en) 2014-05-27
PE20091724A1 (es) 2009-12-06
IL208574A (en) 2014-04-30
AR071203A1 (es) 2010-06-02
EA201071202A1 (ru) 2011-06-30
EP2279183A1 (en) 2011-02-02
CN102066356B (zh) 2014-06-11
EP2279184B1 (en) 2012-08-08
CA2725441A1 (en) 2009-10-22
IL208575A (en) 2014-04-30
EP2279184A1 (en) 2011-02-02
WO2009127678A1 (en) 2009-10-22
AU2009237649A1 (en) 2009-10-22
CN102066356A (zh) 2011-05-18
CL2009000916A1 (es) 2010-12-31
ES2392795T3 (es) 2012-12-13
ZA201006855B (en) 2011-06-29
US8283365B2 (en) 2012-10-09
TW201004939A (en) 2010-02-01
CN102066357A (zh) 2011-05-18
KR20100135911A (ko) 2010-12-27
MX2010011359A (es) 2010-11-12
BRPI0910585A2 (pt) 2015-09-22
JP2011516599A (ja) 2011-05-26
US20110028486A1 (en) 2011-02-03
EP2279183B1 (en) 2012-08-08
JP2011516598A (ja) 2011-05-26
EA018113B1 (ru) 2013-05-30
US20110034515A1 (en) 2011-02-10
WO2009127679A1 (en) 2009-10-22
US8377941B2 (en) 2013-02-19
EA017726B1 (ru) 2013-02-28
IL208574A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
EA201071201A1 (ru) ИНДОЛЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ НИКОТИНОВОГО РЕЦЕПТОРА АЦЕТИЛХОЛИНА ПОДТИПА α-71
TN2010000062A1 (en) Pyrrolidin -2-one derivatives as androgen receptor modulator
AU2011232516A8 (en) Chemical compounds
MX2012003343A (es) Proceso para preparar compuestos azabiciclicos.
MY148574A (en) Indolinone derivatives and process for their manufacture
CY1113131T1 (el) Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1
TW201144306A (en) Bicyclic heteroaryl analogues as GPR119 modulators
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
UY32074A (es) Compuestos de pirrol
EA201290800A1 (ru) Гетероциклическое соединение
GEP20156318B (en) Heteroaryl derivatives as alpha7 nachr modulators
IN2012DN02876A (ru)
ATE510829T1 (de) Neue verbindungen als adenosin-a1-rezeptor- antagonisten
EA201190293A1 (ru) Пролекарства триптолида
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
WO2010057088A3 (en) Pyrrolidinyl modulators of nicotinic acetylcholine receptors
EA201170721A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов рецептора хемокина
EA200970662A1 (ru) Трициклические соединения и их применение в качестве модуляторов глюкокортикоидного рецептора
WO2010035284A3 (en) An improved process for the preparation of rosuvastatin calcium
DK1926732T3 (da) Fremgangsmåde til fremstillingen af carbapenemforbindelser
ATE473968T1 (de) Cycloalkylidinverbindungen als selektive modulatoren des östrogenrezeptors
IN2012DN03104A (ru)
EA201101325A1 (ru) ПРОИЗВОДНЫЕ ИНДОЛА В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРА α7 nAChR
MX2011008126A (es) Compuestos de indol sustituidos como moduladores del receptor 1 de bradiquinina.
EA201170606A1 (ru) Феназопиридиновые соединения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU